Nanopulse Stimulation (NPS) Induces Tumor Ablation and Immunity in Orthotopic 4T1 Mouse Breast Cancer: A Review

Nanopulse Stimulation (NPS) Induces Tumor Ablation and Immunity in Orthotopic 4T1 Mouse Breast Cancer: A Review

Nanopulse Stimulation (NPS) eliminates mouse and rat tumor types in several different animal models. NPS induces protective, vaccine-like effects after ablation of orthotopic rat N1-S1 hepatocellular carcinoma. Here we review some general concepts of NPS in the context of studies with mouse metastat...

Full description

Bibliographic Details
Main Authors:	Stephen J. Beebe, Brittany P. Lassiter, Siqi Guo
Format:	Article
Language:	English
Published:	MDPI AG 2018-03-01
Series:	Cancers
Subjects:	programmed cell death immunogenic cell death immunosuppression tumor microenvironment danger-associated molecular patterns plasma membrane charging time constant (3–10)
Online Access:	http://www.mdpi.com/2072-6694/10/4/97

Similar Items

Ferroptosis: friend or foe in cancer immunotherapy?
by: Robin Demuynck, et al.
Published: (2023-12-01)

Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition
by: Ruiqing He, et al.
Published: (2021-12-01)

Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of Chemotherapy
by: Jean-David Fumet, et al.
Published: (2020-09-01)

Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
by: Xiaoxian Huang, et al.
Published: (2022-12-01)

Nano-Pulse Stimulation Ablates Orthotopic Rat Hepatocellular Carcinoma and Induces Innate and Adaptive Memory Immune Mechanisms that Prevent Recurrence
by: Brittany P. Lassiter, et al.
Published: (2018-03-01)

Engineering nanoliposomes to enhance cancer immunotherapy by reversing immunosuppression and synergistically boosting tumour immunogenicity
by: Chunmei Zhang, et al.
Published: (2023-09-01)

Hypoxia-Driven Immune Escape in the Tumor Microenvironment
by: Alyssa Vito, et al.
Published: (2020-04-01)

Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia
by: Darina Ocadlikova, et al.
Published: (2019-10-01)

Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma
by: Yin Huaqi, et al.
Published: (2023-10-01)

Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas
by: Xin Tang, et al.
Published: (2022-11-01)

Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrug
by: Jinxiao Song, et al.
Published: (2023-03-01)

Suppressing the Hypoxia‐Adenosinergic Axis by a Tailored Nanoreactor for Enhanced Photothermal Immunotherapy
by: Jingjing Gu, et al.
Published: (2024-04-01)

No patient left behind: The promise of immune priming with epigenetic agents
by: Corey A. Carter, et al.
Published: (2017-10-01)

Photodynamic Therapy-Based Dendritic Cell Vaccination Suited to Treat Peritoneal Mesothelioma
by: Natalia Trempolec, et al.
Published: (2020-02-01)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Alfonso Serrano-del Valle, et al.
Published: (2019-04-01)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Alfonso Serrano Del Valle, et al.
Published: (2019-11-01)

Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination
by: Bastien Doix, et al.
Published: (2019-08-01)

Tumor Immunotherapy: Lessons From Autoimmunity
by: Christian eMaueröder, et al.
Published: (2014-05-01)

Effect of pulsed field ablation on solid tumor cells and microenvironment
by: Yujue Wang, et al.
Published: (2022-08-01)

Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity
by: Kohsuke Tsuchiya
Published: (2021-01-01)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
by: Xiaotian He, et al.
Published: (2023-06-01)

Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer
by: Xuejun Gan, et al.
Published: (2023-03-01)

Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies
by: Ángela-Patricia Hernández, et al.
Published: (2021-06-01)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
by: Bingqi Dong, et al.
Published: (2023-05-01)

PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies
by: Ruth Soler-Agesta, et al.
Published: (2022-08-01)

Mathematical Models of Death Signaling Networks
by: Madhumita Srinivasan, et al.
Published: (2022-10-01)

Immature, Semi-mature and Fully mature Dendritic Cells: Towards a DC-cancer cells interface that augments anticancer immunity
by: Aleksandra Maria Dudek, et al.
Published: (2013-12-01)

Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
by: Lucillia Bezu, et al.
Published: (2023-12-01)

Inhibitory DAMPs in immunogenic cell death and its clinical implications
by: Kazukuni Hayashi, et al.
Published: (2021-03-01)

Trial watch: chemotherapy-induced immunogenic cell death in oncology
by: Jenny Sprooten, et al.
Published: (2023-12-01)

Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields
by: Beebe SJ
Published: (2015-05-01)

Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation
by: Qinjun Chen, et al.
Published: (2020-09-01)

Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy
by: Zhicheng Jin, et al.
Published: (2022-10-01)

Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver CancerSummary
by: Jacinth Wing-Sum Cheu, et al.
Published: (2023-01-01)

Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity
by: Zachary L. Z. Hay, et al.
Published: (2022-02-01)

Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma
by: Shuai Han, et al.
Published: (2024-03-01)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
by: Yingshu Cui, et al.
Published: (2023-08-01)

Construction and comprehensive analysis of a novel prognostic signature associated with immunogenic cell death molecular subtypes in patients with bladder cancer
by: Lei Gu, et al.
Published: (2023-08-01)

ICD-related risk model predicts the prognosis and immunotherapy response of patients with liver cancer
by: Duntao Su, et al.
Published: (2023-06-01)

Comprehensive analysis of immunogenic cell death associated genes expression, tumor microenvironment, and prognosis in hepatocellular carcinoma
by: Jiankang Xiang, et al.
Published: (2023-03-01)